This study aims to characterize the pharmacokinetic profile of colchicine after a regimen of
1.8 mg over two hours. A secondary goal is to evaluate the safety and tolerability of this
regimen in healthy volunteers. To this end, all study subjects will be monitored for adverse
effects throughout the entire study period.